1. Home
  2. DRMA vs AGRI Comparison

DRMA vs AGRI Comparison

Compare DRMA & AGRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • AGRI
  • Stock Information
  • Founded
  • DRMA 2014
  • AGRI 2017
  • Country
  • DRMA United States
  • AGRI Canada
  • Employees
  • DRMA N/A
  • AGRI N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • AGRI
  • Sector
  • DRMA Health Care
  • AGRI
  • Exchange
  • DRMA Nasdaq
  • AGRI Nasdaq
  • Market Cap
  • DRMA 3.3M
  • AGRI 3.2M
  • IPO Year
  • DRMA 2021
  • AGRI 2021
  • Fundamental
  • Price
  • DRMA $3.97
  • AGRI $3.71
  • Analyst Decision
  • DRMA Strong Buy
  • AGRI
  • Analyst Count
  • DRMA 1
  • AGRI 0
  • Target Price
  • DRMA $10.00
  • AGRI N/A
  • AVG Volume (30 Days)
  • DRMA 344.3K
  • AGRI 6.7M
  • Earning Date
  • DRMA 11-12-2025
  • AGRI 11-18-2025
  • Dividend Yield
  • DRMA N/A
  • AGRI N/A
  • EPS Growth
  • DRMA N/A
  • AGRI N/A
  • EPS
  • DRMA N/A
  • AGRI N/A
  • Revenue
  • DRMA N/A
  • AGRI $751,781.00
  • Revenue This Year
  • DRMA N/A
  • AGRI $536,026.20
  • Revenue Next Year
  • DRMA N/A
  • AGRI N/A
  • P/E Ratio
  • DRMA N/A
  • AGRI N/A
  • Revenue Growth
  • DRMA N/A
  • AGRI 1205.27
  • 52 Week Low
  • DRMA $3.83
  • AGRI $2.20
  • 52 Week High
  • DRMA $23.70
  • AGRI $58.23
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 38.17
  • AGRI 53.76
  • Support Level
  • DRMA $3.83
  • AGRI $3.30
  • Resistance Level
  • DRMA $4.44
  • AGRI $4.26
  • Average True Range (ATR)
  • DRMA 0.41
  • AGRI 0.35
  • MACD
  • DRMA -0.09
  • AGRI -0.05
  • Stochastic Oscillator
  • DRMA 6.86
  • AGRI 53.90

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.

About AGRI AgriFORCE Growing Systems Ltd.

AgriFORCE Growing Systems Ltd is an Ag-Tech company with a primary focus on developing and utilizing its intellectual property assets for improvements dedicated to the agricultural industry. The company believes that this goal is achieved by using its proprietary IP for solutions in the agricultural industry as well as seeking the development of new IP to both enhance the technology which it has already retained in-house as well as development of new technologies which can increase its footprint in the Ag-Tech space. Its AgriFORCE Brands division is focused on the development and commercialization of plant-based ingredients and products that deliver more nutritious food. It will market and commercialize ingredient supplies, like its Awakened Flour and Awakened Grains.

Share on Social Networks: